Pharmacological treatment of idiopathic pulmonary fibrosis – preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine

Por Myllärniemi, Marjukka, Kaarteenaho, Riitta
Publicado no Eur Clin Respir J (2015)

Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: Current and future perspectives

Por Louhelainen, Noora, Myllärniemi, Marjukka, Rahman, Irfan, Kinnula, Vuokko L
Publicado em 2008

Extracellular Superoxide Dismutase in Pulmonary Fibrosis

Por Gao, Fei, Kinnula, Vuokko L., Myllärniemi, Marjukka, Oury, Tim D.
Publicado em 2008

Idiopathic pulmonary fibrosis - a systematic review on methodology for the collection of epidemiological data

Por Kaunisto, Jaana, Salomaa, Eija-Riitta, Hodgson, Ulla, Kaarteenaho, Riitta, Myllärniemi, Marjukka
Publicado em 2013

Are physicians in primary health care able to recognize pulmonary fibrosis?

Por Purokivi, Minna, Hodgson, Ulla, Myllärniemi, Marjukka, Salomaa, Eija-Riitta, Kaarteenaho, Riitta
Publicado no Eur Clin Respir J (2017)

IMATINIB MESYLATE INHIBITS FIBROGENESIS IN ASBESTOS-INDUCED INTERSTITIAL PNEUMONIA

Por Vuorinen, Kirsi, Gao, Fei, Oury, Tim D., Kinnula, Vuokko L., Myllärniemi, Marjukka
Publicado em 2007

mMRC dyspnoea scale indicates impaired quality of life and increased pain in patients with idiopathic pulmonary fibrosis

Por Rajala, Kaisa, Lehto, Juho T., Sutinen, Eva, Kautiainen, Hannu, Myllärniemi, Marjukka, Saarto, Tiina
Publicado no ERJ Open Res (2017)

Peroxiredoxin II Expression and Its Association With Oxidative Stress and Cell Proliferation in Human Idiopathic Pulmonary Fibrosis

Por Vuorinen, Kirsi, Ohlmeier, Steffen, Leppäranta, Outi, Salmenkivi, Kaisa, Myllärniemi, Marjukka, Kinnula, Vuokko L.
Publicado em 2008

Increased oxidative stress in asymptomatic current chronic smokers and GOLD stage 0 COPD

Por Rytilä, Paula, Rehn, Tiina, Ilumets, Helen, Rouhos, Annamari, Sovijärvi, Anssi, Myllärniemi, Marjukka, Kinnula, Vuokko L
Publicado em 2006

Hemoglobin α and β are ubiquitous in the human lung, decline in idiopathic pulmonary fibrosis but not in COPD

Por Ishikawa, Nobuhisa, Ohlmeier, Steffen, Salmenkivi, Kaisa, Myllärniemi, Marjukka, Rahman, Irfan, Mazur, Witold, Kinnula, Vuokko L
Publicado em 2010

Delay and inequalities in the treatment of idiopathic pulmonary fibrosis: the case of two Nordic countries

Por Pesonen, Ida, Carlson, Lisa, Murgia, Nicola, Kaarteenaho, Riitta, Sköld, Carl Magnus, Myllärniemi, Marjukka, Ferrara, Giovanni
Publicado no Multidiscip Respir Med (2018)

Organisation of diagnosis and treatment of idiopathic pulmonary fibrosis and other interstitial lung diseases in the Nordic countries

Por Bendstrup, Elisabeth, Hyldgaard, Charlotte, Altraja, Alan, Sjåheim, Tone, Myllärniemi, Marjukka, Gudmundsson, Gunnar, Sköld, Magnus, Hilberg, Ole
Publicado no Eur Clin Respir J (2015)

Pirfenidone decreases mesothelioma cell proliferation and migration via inhibition of ERK and AKT and regulates mesothelioma tumor microenvironment in vivo

Por Li, Chang, Rezov, Veronika, Joensuu, Emmi, Vartiainen, Ville, Rönty, Mikko, Yin, Miao, Myllärniemi, Marjukka, Koli, Katri
Publicado no Sci Rep (2018)

Label-free plasma proteomics identifies haptoglobin-related protein as candidate marker of idiopathic pulmonary fibrosis and dysregulation of complement and oxidative pathways

Por Saraswat, Mayank, Joenväärä, Sakari, Tohmola, Tiialotta, Sutinen, Eva, Vartiainen, Ville, Koli, Katri, Myllärniemi, Marjukka, Renkonen, Risto
Publicado no Sci Rep (2020)

Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors α and β

Por Mäkelä, Sari, Savolainen, Hanna, Aavik, Einari, Myllärniemi, Marjukka, Strauss, Leena, Taskinen, Eero, Gustafsson, Jan-Åke, Häyry, Pekka
Publicado em 1999

Bone Morphogenetic Protein-4 Inhibitor Gremlin Is Overexpressed in Idiopathic Pulmonary Fibrosis

Por Koli, Katri, Myllärniemi, Marjukka, Vuorinen, Kirsi, Salmenkivi, Kaisa, Ryynänen, Merja J., Kinnula, Vuokko L., Keski-Oja, Jorma
Publicado em 2006

Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry

Por Kaunisto, Jaana, Salomaa, Eija-Riitta, Hodgson, Ulla, Kaarteenaho, Riitta, Kankaanranta, Hannu, Koli, Katri, Vahlberg, Tero, Myllärniemi, Marjukka
Publicado no ERJ Open Res (2019)

Matrix metalloproteinases -8, -9 and -12 in smokers and patients with Stage 0 COPD

Por Ilumets, Helen, Rytilä, Paula, Demedts, Ingel, Brusselle, Guy G, Sovijärvi, Anssi, Myllärniemi, Marjukka, Sorsa, Timo, Kinnula, Vuokko L
Publicado em 2007

Gremlin-1 Overexpression in Mouse Lung Reduces Silica-Induced Lymphocyte Recruitment – A Link to Idiopathic Pulmonary Fibrosis through Negative Correlation with CXCL10 Chemokine

Por Koli, Katri, Sutinen, Eva, Rönty, Mikko, Rantakari, Pia, Fortino, Vittorio, Pulkkinen, Ville, Greco, Dario, Sipilä, Petra, Myllärniemi, Marjukka
Publicado no PLoS One (2016)

Prognostic role of radiological peritoneal cancer index in malignant peritoneal mesothelioma: national cohort study

Por Salo, Silja A. S., Lantto, Eila, Robinson, Eric, Myllärniemi, Marjukka, Laaksonen, Sanna, Salo, Jarmo A., Rantanen, Tuomo, Ilonen, Ilkka
Publicado no Sci Rep (2020)